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The effect of low birth weight on 
endothelial dysfunction in young adults: 
a retrospective cohort study
ABSTRACT
Aim. To investigate the effect of low birth weight (LBW) on endothelial function, and to determine the role 
of plasma adiponectin in endothelial dysfunction by conducting flow mediated brachial artery (FMBA) 
test or vasodilation response (VR) and by measuring plasma asymmetrical dimethylarginine (ADMA) in 
young adults born with LBW. 
Methods. In a retrospective cohort study, subjects were randomly selected from the Growth Study Cohort 
of Tanjungsari in the Sumedang district of West Java. They consisted of 67 LBW and 67 NBW (normal 
birth weight) young adults. 
Results. The relative risk for LBW to have low brachialis artery vasodilation response was 2.94, 95% 
confidence interval (CI): 1.91–4.53, and to have low plasma adiponectin concentration 1.53, (95% CI: 
1.07–2.18). Multivariate analysis via Hotelling’s trace showed a statistically significant difference (p < 0.001) 
for all variables studied (FMBA, plasma ADMA, and plasma adiponectin concentrations) but simultaneous 
confidence interval measurements indicated that the value of FMBA and the concentration of plasma 
adiponectin were significantly lower, respectively p < 0.001, 95% CI: –4.409–(–2.114), and p = 0.015, 
95% CI: –1.083–(–0.082) in LBW compared to NBW subjects. The correlation between plasma adiponectin 
concentration and plasma ADMA concentration (r = –0.16, p = 0.176), and FMBA (r = 0.13, p = 0.281) 
in LBW subjects were not significant. 
Conclusions. There is an effect of LBW on endothelial function. Plasma adiponectin’s action in endothelial 
dysfunction in young adults with LBW has a potential role which is yet to be defined.
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Introduction
Low birth weight (LBW) may increase the risk of 
cardiovascular diseases during adulthood. Intrauterine 
growth restriction can lead to alteration of organs, func-
tions, and metabolisms and also to persistent endocrine 
disorders [1]. Adiponectin is a protein that is synthe-
sised by fat cells, and plays an important role in foetal 
growth [2, 3]. In LBW, low adiponectin concentration 
persists through childhood and adulthood [4, 5]. Apart 
from an insulin sensitising effect, adiponectin has also 
antithrombotic and antisclerotic properties that directly 
influence the endothelial function [6].
Endothelial dysfunction is a foundation for ath-
erosclerosis. One of the first endothelial functions 
to be disturbed is the vasodilation / vasoconstriction 
balance. Nitric oxide (NO), one of the vasodilators 
which is produced by the endothelial cells, has a very 
short half-life of 3–5 seconds, and clinically can be 
detected as a vasodilatation response (VR) on a flow 
mediated brachial artery (FMBA) test [7–9]. Asymmet-
ric dimethylarginine (ADMA) is a laboratory marker of 
endothelial dysfunction that acts as an endogenous 
inhibitor of endothelial nitric oxide synthase (eNOS), 
an enzyme that competes with arginine, which is a NO 
precursor [10].
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The incidence of LBW in Indonesia is still high, at 
about 11.5% [11], therefore the aim of this study was 
to define the effect of LBW on endothelial function and 
to determine the role of adiponectin in endothelial dys-
function, by addressing the following issues: 1) What 
is the relative risk of LBW to have endothelial dysfunc-
tion?; 2) Do young adults born with LBW have a lower 
plasma adiponectin concentration, a higher plasma 
ADMA concentration, and a lower VR value compared 
to NBW?; 3) Is there a negative correlation between 
plasma adiponectin and plasma ADMA concentrations, 
and a positive correlation between plasma adiponec-
tin concentration and VR value, in young adults born 
with LBW?
Methods
This was a clinical epidemiological study conducted 
in a retrospective fashion from November 2009 until 
January 2010. Subjects were obtained from the Growth 
Study Cohort of Tanjungsari, Sumedang District, West 
Java [12] who fulfilled the inclusion criteria (Fig. 1). LBW 
as a risk or independent variable was compared to a con-
trol group born with NBW, identified 19–21 years earlier. 
The effect of selected dependent variables i.e. plasma 
adiponectin, plasma ADMA, and brachial artery VR, 
were examined.
Inclusion criteria were: male or female; ranging in 
age from 19 to 21; with birth weight and birth length 
data available; had taken part in a previous risk factor 
study; and had been previously randomised. Patients 
were excluded in cases of: chronic renal failure; liver 
disease; heart failure; or consumption of antidiabetic 
drugs, nitrate drugs, steroid drugs or multivitamins.
In this study, chronic renal failure was defined as 
chronic kidney disease stages 3, 4 and 5 with glomeru-
lar filtration rate (GFR) < 59, < 29 and < 15 mL/minute 
per 1.73 m2 [13]. Liver disease was defined as liver cell 
injury with the elevation of alanine aminotransferase 
(ALT) > 1,000 U/L, at least 300 U/L [14]. The epidemi-
ology criteria of the Framingham Study were used to 
consider heart failure which met two major criteria, or 
one major criterion plus two minor criteria [15].
A GE Logic ultrasonograph was used to obtain the 
diameter of brachial artery. This was measured before 
and within the first minute after the occlusion. The VR 
value (in %) is the difference in diameter of brachial 
artery after and before occlusion [9, 16].
Human adiponectin was performed with a sandwich 
enzyme-linked immunosorbent assay (ELISA) that 
used two kinds of anti-human adiponectin monoclonal 
antibodies. The specimens were pretreated, and total 
adiponectin and individual multimers of adiponectin 
were determined selectively, directly or indirectly. 
Reference values: males 2.54–6.06 μg/mL, females 
3.58–9.66 μg/mL. 
ADMA was assayed by a competitive ELISA. ADMA 
in the samples was acylated and competed with solid 
phase bound ADMA for a fixed number of rabbit an-
ti-ADMA antiserum binding sites. The expected values 
were 0.4–0.75 μmol/L.
This study was approved by The Health Research 
Ethics Committee of Dr. Hasan Sadikin General Hos-
pital, Faculty of Medicine, Universitas Padjadjaran, 
Bandung.
Statistical analysis
In order to determine the weight of relative risk, 
pre-defined cut off points were low plasma adiponectin 
concentration, high plasma ADMA concentration, and 
low brachialis artery VR value which were determined 
by diagnostic testing using the Receiver Operating 
Characteristics (ROC) curves. 
Normality testing of data distribution was conduct-
ed before completing the statistical analysis using the 
Lilliefors significance correction. The second question 
was tested in two phases. In the first phase, all depen-
dent variables were tested by multivariate statistical 
Figure 1. Subjects obtained from the Growth Study Cohort 
of Tanjungsari, Sumedang District, West Java
LBW — low birth weight; NBW — normal birth weight
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analysis for two independent samples. The second 
phase used the simultaneous confidence interval to 
determine which mean variable was different. The third 
question was examined using the correlation testing. 
The Pearson’s correlation was used if the data had 
normal distribution. The subject characteristic data 
were stated in mean value and standard deviation (SD). 
Statistical analysis was conducted using the SPSS Win-
dow software version 13.0. The values of p < 0.05 were 
considered statistically significant.
Results 
General characteristics
There were 67 LBW subjects and 67 NBW subjects 
enrolled in this study. None of the patients in either 
group were receiving anti diabetic, antihypertensive, 
nitrate, or vasoactive drugs and/or multivitamins. The 
general characteristics of the two groups were not 
significantly different (Tab. 1).
Relative risk for LBW to have low concentration 
of brachialis artery VR, low plasma adiponectin 
concentration, and high plasma ADMA 
concentration
Cut off point for low plasma adiponectin concentra-
tion from the Receiving Operating Characteristic (ROC) 
curve was £ 4.13 μg/mL and for low VR value was £ 
9.5%, while for high plasma ADMA concentration it 
was ≥ 0.89 mmol/L. Significantly, the LBW group were 
prone to have lower VR and lower plasma adiponectin 
than the NBW group (Tab. 2). 
The mean plasma adiponectin concentration, 
plasma ADMA concentration and VR differences in 
young adults born with LBW and NBW
All three variables showed very significant differences 
(p < 0.001) according to the statistical testing using the 
multivariate analysis for two independent samples. The 
next statistical testing, using the simultaneous confidence 
interval, found significantly different mean variables of 
plasma adiponectin concentration and VR value between 
LBW and NBW. The baseline distribution of brachial 
artery diameter in both groups was not statistically sig-
nificantly different, but the VR value showed a significant 
difference between groups. The mean plasma ADMA 
concentration of LBW was not statistically significantly 
different (p = 0.669) compared to the NBW (Tab. 3).
Correlation between plasma adiponectin, and 
plasma ADMA, and brachialis artery VR in young 
adult subjects born with LBW
The correlation between plasma adiponectin and 
plasma ADMA (r = –0.16, p = 0.176), and between plas-
ma adiponectin and VR (r = 0.13, p = 0.281), in LBW 
subjects were  not significant. A significant correlation 
was found between baseline diameter of brachial artery 
and VR (r = 0.27, p = 0.028), with a smaller brachial 
artery diameter associated with a larger VR. 
Discussion
The main findings of this study are that VR signifi-
cantly differs between LBW and NBW groups, although 
the baseline diameters of brachial artery in both groups 
were similar. 
The endothelial dysfunction was clinically more 
pronounced in the young adult group born with LBW 
compared to NBW that appeared as low VR (8.4% 
vs. 11.6%) on FMBA test. Leeson et al. found that low 
VR in LBW was a result of vascular function alteration 
relating to in-utero growth disturbance [16].
Table 1. General characteristics of young adults born 
with LBW and NBW
Parameters
LBW 
(n = 67)
NBW 
(n = 67)
Age (years) 20.3 (0.5) 20.2 (0.58)
Male (%) 52.2 56.7
SBP [mm Hg] 117 (10) 119 (10)
DBP [mm Hg] 76 (6) 78 (7)
Haemoglobin [gr/dL] 15.0 (1.6) 15.3 (1.3)
Fasting blood glucose [mg/dL] 86.0 (6.7) 84.8 (8.7) 
Total cholesterol [mg/dL] 158.5 (26.7) 161.3 (30.1)
Triglycerides [mg/dL] 84.4 (40.4) 95.10 (51.4)
HDL-C [mg/dL] 44.4 (8.8) 43.5 (8.5)
LDL-C [mg/dL] 100.1 (23.6) 101.8 (24.6) 
SGOT [U/L] 21.6 (6.5) 21.5 (7.0)
SGPT [U/L] 21.5 (13.6)  20.4 (10.9)
Blood urea [mg/dL] 19.1 (5.4) 18.3 (4.5)
Creatinin [mg/dL] 0.68 (0.14) 0.71 (0.16)
Smoker [male, %] 88.6 89.5 
BMI [kg/m2] 20.1 (3.3) 20.7 (3.2)
Diabetes mellitus None None
Hypertension 
(BP ≥ 140/90 mm Hg) (n) 
1 3
LBW — low birth weight; NBW — normal birth weight; SBP — systolic 
blood pressure; DBP — diastolic blood pressure; HDL-C — high 
density lipoprotein cholesterol; LDL-C — low-density lipoprotein cho-
lesterol; SGOT — serum glutamic oxaloacetic transaminase; SGPT  
— serum glutamic-pyruvic transaminase; BMI — body mass index
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Poor nutrition during foetal growth will result in 
alteration of organ structure and function, also in the 
metabolism disturbance that appears in LBW with 
low plasma adiponectin concentration. Adiponectin 
raises NO production through eNOS enzyme stimu-
lation. Plasma adiponectin concentration in this study 
was significantly lower in LBW compared to the NBW 
group. Thiese findings are similar to those of studies 
by Kamoda et al. [4] and Cianfarani et al. [5]. Unlike 
our study, they compared a small for gestational age 
group (birth weight = 2.1 ± 0.4 kg) and an appropriate 
for gestational age group (birth weight = 3.0 ± 0.8 kg). 
In our study, both groups (LBW and NBW) had the 
same BMI (about 20 kg/m2). We could not eliminate 
the possibility that low plasma adiponectin concentra-
tion in LBW was the result of fatty tissue malfunction 
according to Barker & Hales’ study [1] and as a result 
of genetic factors such as single nucleotide polymor-
phisms 276 on adiponectin gene [6]. Therefore further 
studies are needed.
In this study, no significant correlation between 
plasma adiponectin and VR, or between plasma adi-
ponectin and plasma ADMA, were found. Adiponectin 
might have some effect on endothelial dysfunction of 
young adults with LBW. 
Other factors might have influenced the final results, 
and this precludes us from drawing definite conclusions 
before thorough evaluation.
There are a variety of vascular or endothelial func-
tions, but the vasodilation / vasoconstriction balance 
is the first to be affected [17]. In addition to the NO 
vasodilator synthesis disturbance, the potential role 
of excessive vasoconstrictors in LBW subjects such 
as endothelin-1, angiotensin II, thromboxane A2, and 
prostagladin H2 deserve further investigation. 
The mean plasma ADMA concentration of the LBW 
group was not significantly different to the NBW group. 
Only a few studies have examined the protein arginine 
N-methyltransferase (PRMT) activity regulation. The 
study by Osanai et al. [18] found that ADMA concentra-
Table 2. Relative risk for LBW to have low VR, low plasma adiponectin concentration, and high plasma ADMA 
concentration
Variables
LBW
(n = 67)
NBW 
(n = 67) p value RR (95% CI)
Adiponectin 0.016 1.53 (1.07–2.18)
≤ 4.13 μg/mL 41 (60.3%) 27 (39.7%)
> 4.13 μg/mL 26 (39.4%) 40 (60.6%)
VR < 0.001 2.94 (1.91–4.53)
≤ 9.5% 50 (74.6) 17 (25.4)
> 9.5% 17 (25.4) 50 (74.6)
ADMA 0.216 1.32 (0.89–1.96)
≥ 0.89 mmol/L 12 (63.2%) 7 (36.8%)
< 0.89 mmol/L 55 (47.8%) 60 (52.2%)
Note : Chi Square test
LBW — low birth weight; NBW — normal birth weight; VR — vasodilation response; RR — relative risk for LBW; CI — confidence interval; ADMA 
— asymmetrical dimethylarginine
Table 3. Mean plasma adiponectin concentration, plasma ADMA concentration, and brachialis artery VR differences 
between young adults born with LBW and NBW
Variables
LBW
(n = 67)
NBW
(n = 67) p
95% CI for 
difference
Total (adiponectin, ADMA and brachial artery VR)* < 0.001*
Plasma adiponectin [μg/mL] 4.07 (1.29) 4.64 (1.61) 0.015** –1.083–(–0.082)**
Brachialis artery VR (%) 8.40 (3.06) 11.66 (3.63) < 0.001** –4.409–(–2.114)**
Baseline diameter of brachialis artery [cm] 3.35 (0.47) 3.33 (0.42) 0.758***
Plasma ADMA [μmol/L] 0.71 (0.15) 0.69 (0.15) 0.669** –0.041–(0.064)**
LBW — low birth weight; NBW — normal; birth weight; CI — confidence interval; *Hotelling’s Trace; **Simultaneous Confidence Interval; ***Inde-
pendent test
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tions were influenced by shear stress. In a physiologic 
state, shear stress increases PRMT-1 expression and 
ADMA synthesis through NF-kB pathway activation. 
However, in the presence of shear stress, dimethylargi-
nine dimethylamin hydrolase-II (DDAH-II) activity would 
also increase, resulting in ADMA degradation. In this 
study, the blood samples for ADMA examination were 
obtained before conducting an FMBA test, thus pre-
venting any differences between the two groups. Ox-
idative stress that results in ADMA accumulation [19] 
could be eliminated only if the general characteristics 
of both groups were similar i.e.. smoking, systolic and 
diastolic blood pressure, blood glucose concentration, 
and blood fat concentration between the LBW and 
NBW groups. 
One factor that could influence plasma adiponectin 
and ADMA is TNFa. Tumour necrosis factor a inhibits 
adiponectin production [20–22], but induces ADMA ac-
cumulation [23]. The possibility of fatty tissue function 
disturbance [1], especially in TNFa synthesis which is 
strictly related to adiponectin production and ADMA 
accumulation, cannot be ruled out.
Low plasma adiponectin concentration and en-
dothelial dysfunction condition persist throughout 
childhood and adulthood. A nonsignificant correlation 
between plasma adiponectin and plasma ADMA con-
centration, and a nonsignificant correlation between 
plasma adiponectin concentration and VR, revealed no 
potential role for adiponectin in endothelial dysfunction 
in LBW. There are other factors at the cellular level 
that influence endothelial function, and this possibility 
needs further investigation. 
Finally, beyond the small sample size, another 
potential limitation is the involvement of intrauterine 
growth retardation (IUGR), and preterm subjects in 
the LBW group. The findings of this report therefore 
deserve confirmation in future studies that are ade-
quately powered.
Conclusion
LBW modulates endothelial function. LBW subjects, 
compared to NBW subjects, have lower VR and plasma 
adiponectin concentration. There may be a small role 
played by plasma adiponectin in endothelial dysfunc-
tion of young adults with LBW. However, other variables 
could play important roles, and further studies are 
needed before definite conclusions regarding plasma 
adiponectin can be drawn.
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